Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 2, 2006, Pages 666-675

  Slomiany, Mark G ^a   Rosenzweig, Steven A ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COBALT CHLORIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; SOMATOMEDIN C; VASCULOTROPIN;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; HYPOXIA; NORTHERN BLOTTING; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN SECRETION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANOXIA; ANTI-BACTERIAL AGENTS; CELL LINE; COBALT; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; LIGANDS; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SIGNAL TRANSDUCTION; SIROLIMUS; STIMULATION, CHEMICAL; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33745947014     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.104158     Document Type: Article

References (40)

1. Abdelrahim M and Safe S (2005) Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins. Mol Pharmacol 68:317-329.
2. Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, D'Amore PA, and Miller JW (1996) Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 114:66-71.
3. Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, and Smith LE (1995) Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92:10457-10461.
4. Amin R, Puklin JE, and Frank RN (1994) Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Investig Ophthalmol Vis Sci 35:3178-3188.
5. Beretta L, Gingras AC, Svitkin YV, Hall MN, and Sonenberg N (1996) Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO (Eur Mol Biol Organ) J 15:658-664.
6. Brahimi-Horn C, Mazure N, and Pouyssegur J (2005) Signalling via the hypoxiainducible factor-1α requires multiple posttranslational modifications. Cell Signal 17:1-9.
7. Brunn GJ, Williams J, Sabers C, Wiederrecht G, Larwence JC Jr, and Abraham RT (1996) Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO (Eur Mol Biol Organ) J 15:5256-5267.
8. Cui JZ, Kimura H, Spee C, Thumann G, Hinton DR, and Ryan SJ (2000) Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate. Graefes Arch Clin Exp Ophthalmol 238:326-333.
9. D'Angelo G, Duplan E, Vigne P, and Frelin C (2003) Cyclosporin A prevents the hypoxic adaptation by activating hypoxia-inducible factor-1α Pro-564 hydroxylation. J Biol Chem 278:15406-15411.
10. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H-J, Benedict W, and Bouck NP (1999) Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science (Wash DC) 285:245-248.
11. Epstein AC, Gleadle JM, McNeill LA, Hewitson KS, O'Rourke J, Mole DR, Mukherji M, Metzen E, Wilson MI, Dhanda A, et al. (2001) C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107:43-54.
12. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, and Semenza GL (1999) Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2. Cancer Res 59:3915-3918.
13. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, and Semenza GL (2002) Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277:38205-38211.
14. Jiang BH, Rue E, Wang GL, Roe R, and Semenza GL (1996) Dimerization, DNA binding and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271:17771-17778.
15. Jones SM and Howell KE (1997) Phosphatidylinositol 3-kinase is required for the formation of constitutive transport vesicles from the TGN. J Cell Biol 139:339-349.
16. Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NA, Li W, Connolly E, O'Neill CA, and Miller JW (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120:338-346.
17. Lambooij AC, van Wely K, Lindenbergh-Kortleve D, Kuijpers R, Kliffen M, and Mooy C (2003) Insulin-like growth factor-1 and its receptor in neovascular age-related macular degeneration. Investig Ophthalmol Vis Sci 44:2192-2198.
18. Levy AP, Levy NS, Wegner S, and Goldberg MA (1995) Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270: 13333-13340.
19. Miele C, Rochford JJ, Filippa N, Giorgetti-Peraldi S, and Van Obberghen E (2000) Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J Biol Chem 275:21695-21702.
20. Milanini-Mongiat J, Pouyssegur J, and Pages G (2002) Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277:20631-20639.
21. Moriarty P, Boulton M, Dickson A, and McLeod D (1994) Production of IGF-1 and IGF binding proteins by retinal cells in vitro. Br J Ophthalmol 78:638-642.
22. Mukhopadhyay D, Knebelmann B, Cohen H, Ananth S, and Sukhatme V (1997) The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol Cell Biol 17:5629-5639.
23. Ng EW and Adamis AP (2005) Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Can J Ophthalmol 40:352-368.
24. Punglia RS, Lu M, Hsu J, Kuroki M, Tolentino MJ, Keough K, Levy AP, Levy NS, Goldberg MA, D'Amato RJ, et al. (1997) Regulation of VEGF expression by IGF-1. Diabetes 46:1619-1626.
25. Robinson SA and Rosenzweig SA (2004) Synthesis and characterization of biotinylated forms of insulin-like growth factor-1: topographical evaluation of the IGF-1/IGFBP-2 AND IGFBP-3 interface. Biochemistry 43:11533-11545.
26. Rosenthal R, Wohlleben H, Malek G, Schlichting L, Thieme H, Bowes Rickman C, and Strauss O (2004) Insulin-like growth factor-1 contributes to neovascularization in age-related macular degeneration. Biochem Biophys Res Commun 323:1203-1208.
27. Rosenzweig SA (2004) What's new in the IGF-binding proteins? Growth Horm IGF Res 14:329-336.
28. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, and Giallongo A (1996) Hypoxia response elements in the aldolase A, enolase 1 and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271:32529-32537.
29. Slomiany MG, Black LA, Kibbey MM, Day TA, and Rosenzweig SA (2006) IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma. Biochem Biophys Res Commun 342:851-858.
30. Slomiany MG and Rosenzweig SA (2004a) Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19. Am J Physiol 287:C746-C753.
31. Slomiany MG and Rosenzweig SA (2004b) IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1α expression and activity in retinal pigment epithelial cell line D407. Investig Ophthalmol Vis Sci 45:2838-2847.
32. Spilsbury K, Garrett KL, Shen WY, Constable IJ, and Rakoczy PE (2000) Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol 157:135-144.
33. Stein RC and Waterfield MD (2000) PI3-kinase inhibition: a target for drug development? Mol Med Today 6:347-357.
34. Strauss O (2005) The retinal pigment epithelium in visual function. Physiol Rev 85:845-881.
35. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, and Van Obberghen E (2002) Insulin stimulates hypoxia-inducible factor 1 through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 277:27975-27981.
36. Wada M, Ogata N, Otsuji T, and Uyama M (1999) Expression of vascular endothelial growth factor and its receptor (KDR/flk-1) mRNA in experimental choroidal neovascularization. Curr Eye Res 18:203-213.
37. Waldbillig RJ, Pfeffer BA, Schoen T, Adler A, Shen-Orr Z, Scavo L, LeRoith D, and Chader G (1991) Evidence for an insulin-like growth factor autocrine-paracrine system in the retinal photoreceptor pigment epithelial cell complex. J Neurochem 57:1522-1533.
38. Wood W, Cachianes G, Henzel W, Winslow G, Spencer S, Hellmiss R, Martin J, and Baxter R (1988) Cloning and expression of the GH dependent insulin like growth factor binding protein. Mol Endocrinol 2:1176-1185.
39. Xu Q, Briggs J, Park S, Niu G, Kortylewski M, Zhang S, Gritsko T, Turkson J, Kay H, Semenza GL, et al. (2005) Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. 24:5552-5560.
40. Yuan Y, Hilliard G, Ferguson T, and Millhorn DE (2003) Cobalt inhibits the interaction between hypoxia-inducible factor-α and von Hippel-Lindau protein by direct binding to hypoxia-inducible factor-α. J Biol Chem 278:15911-15916.